DrugPatentWatch

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Generic Name: nitric oxide

Summary for Generic Name: nitric oxide

Tradenames:1
Patents:12
Applicants:1
NDAs:1
Drug Master File Entries: see list6
Suppliers: see list1
Formulation / Manufacturing:see details

Pharmacology for Ingredient: nitric oxide

Drug ClassVasodilator
Physiological EffectVasodilation

Clinical Trials for: nitric oxide

Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children
Status: Recruiting Condition: Acute Chest Syndrome; Sickle Cell Disease

Comparison of Inhaled Nitric Oxide and Oxygen in Patient Reactivity During Acute Pulmonary Vasodilator Testing
Status: Completed Condition: Idiopathic Pulmonary Arterial Hypertension; Congenital Heart Disease With Pulmonary Hypertension; Cardiomyopathy

Use of Inhaled Nitric Oxide to Prevent Pulmonary Hypertension Associated to Stored Blood Transfusion
Status: Not yet recruiting Condition: Hypertension, Pulmonary; Hemolysis

Effect of Nitric Oxide (NO) on Ischemic/Reperfusion Injury During Extended Donor Criteria (EDC) Liver Transplantation
Status: Recruiting Condition: Liver Transplantation; Ischemia/Reperfusion Injury; Oxidative Injury

Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia
Status: Completed Condition: Pulmonary Disease

The Effects of Nitric Oxide for Inhalation During Left Ventricular Assists Device (LVAD) Implantation
Status: Completed Condition: Congestive Heart Failure

Phase II Evaluation of Exhaled Nitric Oxide (NO)
Status: Completed Condition: Lung Cancer

Exhaled Nitric Oxide and Nasal Lavage Fluid
Status: Completed Condition: Asthma

Inhaled Nitric Oxide by Oxygen Hood in Neonates
Status: Completed Condition: Respiratory Failure; Infant; Persistent Fetal Circulation

Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH)
Status: Active, not recruiting Condition: Pulmonary Arterial Hypertension; Pulmonary Hypertension

Courtesy of ClinicalTrials.org
See more clinical trials for this drug

Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Ino
INOMAX
nitric oxide
GAS;INHALATION020845Dec 23, 1999RXYes<disabled>PEDIATRIC EXCLUSIVITY
Ino
INOMAX
nitric oxide
GAS;INHALATION020845Dec 23, 1999RXYes<disabled>
Ino
INOMAX
nitric oxide
GAS;INHALATION020845Dec 23, 1999RXYes8,573,210*PED<disabled>Y
Ino
INOMAX
nitric oxide
GAS;INHALATION020845Dec 23, 1999RXYes8,573,209*PED<disabled>Y
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000  2001  2002  2003  2004  2005  2006  2007  2008  2009 
 2010  2011  2012  2013 

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc